Short Interest & Thesis

Short Interest and Thesis — Molina Healthcare (MOH)

Bottom line

Reported short interest in MOH is moderate, declining, and not crowded: roughly 4.9% to 6.3% of float with 1.8 to 3.5 days-to-cover across third-party aggregators of FINRA/NYSE position data, well below "crowded short" thresholds. Reported positioning is not decision-useful as a squeeze setup. What is decision-useful is the public short-thesis ledger: an active securities class action over 2025 medical-cost-trend disclosures, a confirmed $40M Texas AG Medicaid-fraud settlement, three 2025 guidance cuts, and a 55% FY2026 EPS reset — all unresolved bear arguments that anyone running a short on this name is already trading. No dedicated short-seller report (Hindenburg/Muddy Waters/Spruce Point-style campaign) is on record.

Reported positioning across public aggregators

Reported short interest is consistent within a narrow band across five third-party aggregators: 2.5 to 3.2 million shares short, 4.9 to 6.3 percent of public float, and 1.8 to 3.5 days to cover on recent ADV. Position counts have fallen month-over-month as Q1 2026 results reaffirmed full-year 2026 premium and adjusted-earnings guidance and the sector tape improved on the 2027 Medicare Advantage rate update.

The five aggregator readings cluster between 2.5M and 3.2M shares short on a public float Finviz cites at 51.35M shares. The spread between sources reflects different float definitions and different reporting cuts — not a disagreement about the underlying FINRA data. None of these readings sit anywhere near a crowded-short threshold (10%+ float, 8+ days-to-cover) that would on its own create squeeze risk into a positive catalyst.

Crowding versus liquidity

At an aggregator midpoint of ~2.7M shares short against 20-day ADV of ~889k shares, the entire reported short book could be covered inside three to four trading sessions at current tape participation. Using the larger trailing average volume Finviz reports (~1.41M shares/day) the figure compresses below two sessions. On the liquidity tab MOH is classified as institutionally tradable and is not flagged as thin. The implication: positioning is not a binding constraint on either side — neither shorts nor longs face structural exit risk from the size of the float-weighted book.

Public short-thesis ledger

The credible bear case on MOH is public, well-documented, and dominated by legal/litigation events rather than a dedicated short-seller campaign. Multiple plaintiff-firm investigations and one filed securities class action cover the same Class Period (February 5 – July 23, 2025). The single most important unresolved item is the medical-cost-trend disclosure question now in front of a federal court.

Borrow pressure — evidence is thin

No primary or third-party borrow-fee, utilization, lendable-supply, or hard-to-borrow data was staged for this run, and no flag of HTB or borrow squeeze surfaced in public commentary. Finviz reports MOH as shortable through standard channels ("Option / Short: Yes / Yes"), which rules out an HTB notation at the retail-broker level. With aggregator short float in the 5 percent band, lendable supply is unlikely to be a binding constraint at a Russell mid-cap held 108 percent by institutions (i.e., heavy institutional ownership creating a deep lendable inventory).

Treat the borrow read as inferred, not measured. If a paid borrow feed surfaces a sudden utilization spike into a catalyst, the conclusion can change.

Peer comparison — short interest is roughly inline

Among large managed-care peers, MOH and Centene (CNC) both sit in the 3 to 6 percent short-float / 2.5 to 3.5 days-to-cover band. UNH, ELV, and HUM short interest is not staged for this run and would be needed to complete the peer table — current public commentary does not flag any of them as crowded shorts in the post-Medicare-Advantage-rate-update tape.

Benzinga Pro's peer-group average short-float is 5.51 percent, putting MOH at roughly the peer-group average, modestly above CNC, and likely above the larger-cap UNH/ELV (which tend to carry lower percentage shorts because of their float size). The takeaway is that MOH is not unusually shorted for a Medicaid-exposed managed-care name in a stress cycle.

Market setup — positioning is a follower, not a driver

The 2025 drawdown and the February 6, 2026 -28% gap on the 2026 EPS reset were driven by fundamental guidance events, not by a positioning unwind. Realized 30-day vol of 41% sits in the 80th percentile band of MOH's own history, consistent with continued single-stock event risk into the July 22 Q2 print rather than crowding-related fragility. Short interest is small enough that even a clean Q2 beat would not on its own deliver a squeeze; it would deliver a normal fundamental re-rate.

Evidence quality and what would change the call